<?xml version="1.0" encoding="utf-8"?>
    <rss version="2.0">
      <channel xmlns:content="http://purl.org/rss/1.0/modules/content/">
        <title>Frontiers in Cell Death | New and Recent Articles</title>
        <link>https://www.frontiersin.org/journals/cell-death</link>
        <description>RSS Feed for Frontiers in Cell Death | New and Recent Articles</description>
        <language>en-us</language>
        <generator>Frontiers Feed Generator,version:1</generator>
        <pubDate>2026-05-02T04:57:03.989+00:00</pubDate>
        <ttl>60</ttl>
        <item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2026.1680195</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2026.1680195</link>
        <title><![CDATA[Hazard identification and the harmful effects of organophosphates and carbamates in bioethical models: a review]]></title>
        <pubdate>2026-03-06T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Chiara Gambardella</author><author>Pietro Soro</author><author>Ombretta Paladino</author><author>Carla Falugi</author><author>Francesco Misurale</author><author>Marco Faimali</author>
        <description><![CDATA[Pesticides are an emerging category of contaminants employed in agriculture or for domestic use. Among them, anti-cholinesterase insecticides are the most extensively applied. These are neurotoxic compounds released into the environment in an estimated millions of tons per year, posing serious risks to both environmental and human health. This review examines the current literature on hazard identification and the assessment of two major classes of neurotoxic compounds—organophosphates (OPs) and carbamates (CBs)—in relation to human and environmental health. We report the harmful effects of OPs and CBs on humans and present bioethical models as alternatives to vertebrates in toxicological testing. We describe the most utilized bioassays, employing a range of experimental models (cells, monolayer cultures, spheroids, and whole organisms) exposed to different doses of OPs and CBs, to identify and quantify the most sensitive biological responses (endpoints and biomarkers). This novel approach aims to improve predictive capacity and strengthen the risk assessment of human and environmental health. In conclusion, in vitro or non-mammalian models are promising alternatives for assessing human health risks caused by OPs and CBs, in line with the “Replacement, Reduction, and Refinement” (3R) principle.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2026.1793102</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2026.1793102</link>
        <title><![CDATA[Non-canonical regulated cell death and epigenetic mechanisms in the nervous system]]></title>
        <pubdate>2026-02-26T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Adalberto Merighi</author><author>Claudia Castagna</author><author>Marco Sbriz</author><author>Laura Lossi</author>
        <description><![CDATA[Classical apoptosis alone does not sufficiently elucidate neuronal loss in the developing, aging, and pathological nervous system. Growing data show that neurons and glial cells, under different physiological or pathological conditions, undergo multiple non-canonical regulated cell death (RCD) pathways, including necroptosis, ferroptosis, parthanatos, autophagy-dependent cell death, and inflammatory forms such as pyroptosis. These different types of death are highly context-dependent, often incomplete, and frequently overlap at the molecular and morphological levels. In this article, we examine the main non-canonical mechanisms of cell death in the nervous system. We discuss how they are specialized to specific cell types/pathological contexts. Epigenetic alterations in the aging brain can affect cell death by regulating gene expression, leading to either increased cell death or cellular senescence, a process by which cells develop resistance to apoptosis. The interplay between non-canonical RCD and epigenetic modifications is reciprocal, with epigenetic alterations serving as both a cause and a consequence of physiological and pathological aging, significantly influencing neuronal fate. We also review current knowledge of RCD regulation through direct epigenetic mechanisms, epigenetic permissiveness or priming through long-term chromatin remodeling, and indirect or associative links involving metabolic or stress-responsive pathways that converge on epigenetic modifiers.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2026.1770008</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2026.1770008</link>
        <title><![CDATA[Thirty years of reaper: lessons learned from programmed cell death in Drosophila]]></title>
        <pubdate>2026-02-16T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Hermann Steller</author>
        <description><![CDATA[April 2024 marked the 30-year anniversary of the publication of reaper, the first description of a Drosophila cell death gene. This discovery established the foundation for modern apoptosis research in Drosophila and fundamentally reshaped studies on programmed cell death (PCD). This review provides a historical and mechanistic overview of apoptosis research in Drosophila, with a particular emphasis on the discovery and legacy of reaper. Rather than providing a comprehensive review of the entire field, this article emphasizes some of the main lessons learned from Drosophila cell death research and their general impact. One of the first lessons was that reaper is transcriptionally activated by many different death-inducing signals, suggesting that apoptosis is a transcriptionally regulated, developmentally patterned process. Mechanistically, reaper and its neighboring genes head involution defective (hid), grim, and sickle, collectively referred to as RHG genes, induce apoptosis by neutralizing the anti-apoptotic Drosophila Inhibitor of Apoptosis-1 (DIAP1) protein. DIAP1 is required to prevent unwanted caspase activation and apoptosis in virtually all somatic cells. RHG proteins de-repress caspases by inducing the self-conjugation and degradation of this E3-ligase protein. This mechanism provided a conceptual bridge to mammalian IAP-antagonists such as Smac/DIABLO and ARTS, which were discovered 6 years later. The RHG proteins introduced a fundamental principle in cell death regulation: that apoptosis in higher animals can be triggered by precisely controlled expression of IAP antagonists, rather than activation of caspases alone. Over 3 decades, Drosophila has proven indispensable in elucidating caspase regulation in vivo, transcriptional control of cell death, the role of apoptosis in developmental and tissue morphogenesis, the hormonal regulation of apoptosis, ubiquitin-proteasome-mediated protein degradation in cell death, apoptosis-induced proliferation, and non-apoptotic cell death pathways, including autophagic, necrotic, and inflammatory forms of regulated cell death. Due to its genetic and anatomical accessibility, Drosophila continues to drive conceptual advances with relevance to cancer, neurodegeneration, immunity, and regeneration.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1632653</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1632653</link>
        <title><![CDATA[Expression of two histone H4 epigenetic modifications (lysine 12 acetylation and lysine 20 trimethylation), and the senescence marker lamin B1 in the postnatal, adult, and old mouse brain]]></title>
        <pubdate>2025-10-30T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Marco Sbriz</author><author>Maftuna Shamshiddinova</author><author>Laura Lossi</author><author>Adalberto Merighi</author>
        <description><![CDATA[Aging is a complex biological process characterized by gradual cellular and molecular changes contributing to cognitive decline and neurodegeneration. Histone alterations regulate gene expression, chromatin organization, and neuronal function. Additionally, nuclear architecture undergoes significant alterations during aging, with lamin B, a key component of the nuclear lamina, playing a pivotal role in maintaining the stability of the cell nucleus. Lamin B1 (LB1) dysfunction has been implicated in age-related neuronal decline, as aberrations in its expression or processing can lead to nuclear deformation, impaired gene regulation, and increased susceptibility to DNA damage to the point that LB1 is now regarded as a cellular senescence marker. We have studied the immunocytochemical localization of trimethylated histone H4 at lysine 20 (H4K20me3), acetylated histone H4 at lysine 12 (H4K12ac), and LB1 in the brain of postnatal day 5 (P5) pups, mature adult (9–10 months), and old (24 months) mice, aiming to find a correlation between histone epigenetic modifications, senescence, and cell death, with particular attention to the hippocampus and cerebral cortex. We first describe the distribution of the three molecules throughout the different brain regions, and confirm these data with Western blot analysis. We then show that H4K20me3 and H4K12ac can be detected in both neurons and glia. After inferential statistics and effect size analysis, we demonstrate that a biologically meaningful reduction in the expression of the three molecules occurs in the old hippocampus. In addition, a biologically relevant decrease in the degree of cellular coexistence of H4K20me3 and H4K12ac was observed in the hippocampus and cerebral cortex. Understanding how histone and LB1 modifications influence brain aging provides valuable insights into the molecular pathways that drive neurodegeneration and may offer clues to better understanding age-related cognitive disorders.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1677498</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1677498</link>
        <title><![CDATA[Sacrificing cells of the cyst: non-apoptotic cell death in germline cysts via acidification]]></title>
        <pubdate>2025-10-29T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Shruthi Bandyadka</author><author>Logan Tohline</author><author>Georgette-Vanelle Wandji</author><author>Hila Toledano</author><author>Kimberly McCall</author>
        <description><![CDATA[Cell death shapes multicellular organism development and sustains tissue and organ homeostasis. Great progress has been made in understanding the breadth of physiological and biochemical diversity in cell death and clearance pathways, which play vital roles in organismal development and health. While apoptosis and necrosis have been studied extensively across many model systems and contexts, the discovery of non-apoptotic paradigms of cell death and their roles in disease has greatly expanded the field. Collectively called Regulated Cell Death, these death pathways operate in a tissue and context-dependent manner. Germ cells in many organisms develop in cysts of interconnected cells, and may die in response to environmental or developmental cues. Recent findings suggest that germ cell cysts may use a common mechanism of non-apoptotic cell death involving phagocytic and lysosomal activity of surrounding somatic cells. Cyst cell death has been analyzed most thoroughly in the Drosophila adult ovary and testis, with remarkable similarity to cyst cell death in mouse adult testis and fetal ovary. In this review, we highlight recent progress in deciphering germline cyst cell death.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1628470</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1628470</link>
        <title><![CDATA[Copper-induced cell death mechanisms and their role in the tumor microenvironment]]></title>
        <pubdate>2025-10-20T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Yujuan Jiao</author><author>Hongxin Wang</author><author>Meng Zhu</author><author>Tengteng Liu</author><author>Yuqi Li</author><author>Shuo Yang</author><author>Minghui Zhang</author><author>Lei Zhang</author>
        <description><![CDATA[Copper is an essential cofactor for all organisms. However, it can become toxic if its concentration rises above a specific level. This level is controlled by evolutionary conserved homeostatic mechanisms. Recently, a new type of cell death called cuproptosis has been found. The process represents a copper-dependent, regulated form of cell death that is distinct from all known death mechanisms and relies on mitochondrial respiration. The mechanism of cuproptosis involves the direct binding of copper to lipidated parts in the tricarboxylic acid (TCA) cycle. This results in the abnormal aggregation of lipoylated proteins and the destabilization of iron-sulfur cluster (Fe-S) proteins. These events induce proteotoxic stress, ultimately leading to cell death. Copper-induced cell death is controlled by proteolipid acylation, which is mediated by the mitochondrial iron-sulfur protein FDX1. Copper overload also inhibits the biosynthesis of iron-sulfur (Fe-S) clusters and impairs the activity of Fe-S enzymes. As a result, mitochondrial function is disrupted. Both copper-induced cell death and impaired copper homeostasis arise from the same mechanistic basis. The expression of copper import gene SLC31A1 (CTR1) and export genes ATP7A and ATP7B significantly influences cuproptosis. The tumor suppressor p53 may participate in this process by modulating glycolysis and mitochondrial metabolism. In contrast, glutathione (GSH) reduces copper ion cytotoxicity by binding copper to form a complex. The growth and spread of tumor cells is more dependent on copper than that of normal cells.The copper ionophore elesclomol (ES) kills cancer cells by transporting copper ions into them. This ES-Cu complex not only inhibits cancer cell proliferation but also activates an immune response. Moreover, when ES is combined with αPD-L1, it might increase the effectiveness of cancer treatment. This gives a new idea for treating cancer.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1704003</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1704003</link>
        <title><![CDATA[Editorial: Women in cell death research]]></title>
        <pubdate>2025-09-26T00:00:00Z</pubdate>
        <category>Editorial</category>
        <author>Rosa Bonaventura</author><author>Chiara Gambardella</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1669955</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1669955</link>
        <title><![CDATA[Lysosomal membrane-permeabilization (LMP) and -rupture (LMR) are distinct for cell death]]></title>
        <pubdate>2025-09-12T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Tetsumori Yamashima</author>
        <description><![CDATA[Lysosome is crucial for maintaining cellular homeostasis, but disintegrity of its limiting membrane affects the cell death fate. From 1972 to 1999, via the cytochemistry of cultured cells which were exposed to stresses, Brunk et al. defined lysosomal membrane permeabilization (LMP) as leakage through the ultrastructurally-intact limiting membrane. In 1996, via the electron microscopic analysis of the monkey hippocampal CA1 neurons after transient ischemia, Yamashima et al. first identified lysosomal membrane rupture (LMR) as an apparent disruption of the limiting membrane. To elucidate the mechanism of lysosomal cell death, it is indispensable to precisely differentiate LMP and its extensive form LMR. LMP indicates formation of ultrastructurally-undetectable, tiny pores at the lysosomal limiting membrane that allow selective leakage of lysosomal contents. LMP contributes to amplification of the cell death signal, and participates in apoptosis. In contrast, LMR indicates presence of larger holes that cause acute and massive leakage of hydrolytic cathepsin enzymes. LMR leads to the rapid and explosive vanishment of lysosomes, which proceeds along with vanishment of cells, i.e., necrosis. Each representative form of cell death is carried out in human diseases, depending upon the size and number of perforations, the amount of leakage, and the cellular context. The modality of the lysosomal membrane disintegrity, LMP or LMR, determines the cell death fate. It is likely that apoptosis occurs by the proteolytic activation of caspases via LMP, whereas necrosis occurs by the calpain-cathepsin cascade via LMR. This paper is to review ultrastructural evidences of LMR which were identified in diverse pathologic conditions of C. elegans, mice, monkeys, and humans. For elucidating mechanisms of each cell death in the organs affected by stresses, LMP and LMR should be precisely differentiated by electron microscopy. Herein, other lysosomal cell death such as pyroptosis and ferroptosis was discussed to make the difference clear. Ferroptosis might share very similar calpain-cathepsin cascade with necrosis.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1658598</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1658598</link>
        <title><![CDATA[C/EBPβ deficiency enhances keratinocyte apoptosis after UVB-induced DNA damage via regulation of the type I IFN and TNF responses]]></title>
        <pubdate>2025-09-03T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Emma E. Tobin</author><author>Ayushma Sharma</author><author>Samantha T. Kros</author><author>Dereje D. Jima</author><author>Sophia C. Gray</author><author>Jonathan R. Hall</author>
        <description><![CDATA[The epidermis is routinely subjected to DNA damage induced by ultraviolet B (UVB) solar radiation. In addition to activating canonical DNA damage responses such as cycle cell checkpoints and DNA repair, UVB-induced DNA damage can also activate additional signaling pathways including inflammatory responses. The pathways activated downstream of UVB-induced DNA damage have a critical role in determining cellular survival to UVB radiation. Here we report that loss of CCAAT/enhancer binding protein β (C/EBPβ) in mouse keratinocytes results in enhanced UVB-induced apoptosis through activation of extrinsic apoptosis genes cleaved caspase-8 and truncated BH3 interacting-domain death agonist (tBid). RNAseq and Ingenuity Pathway Analysis of UVB-treated C/EBPβ−/− primary keratinocytes revealed an enrichment of inflammatory signaling pathways, including the type I interferon (IFN-I) pathway as the most enriched pathway. Numerous IFN-I stimulated genes were up-regulated in UVB-treated C/EBPβ−/− keratinocytes, including genes that regulate extrinsic apoptosis. Inhibition of the interferon-α/β receptor or the associated kinase Tyk2 greatly reduced cell death in UVB-exposed C/EBPβ deficient keratinocytes, demonstrating the dependence of IFN signaling in C/EBPβ regulated apoptosis. The apoptosis inducing cytokine tumor necrosis factor alpha (TNF-α) was identified as one of the most significant upstream regulators activated in UVB-exposed C/EBPβ−/− keratinocytes compared to UVB exposed wild type control. UVB-exposed C/EBPβ−/− keratinocytes displayed increased expression of TNF-α and the enhanced apoptosis in C/EBPβ−/− keratinocytes was suppressed by a TNF-α neutralizing antibody. Our results indicate that loss of C/EBPβ enhances activation of a non-canonical UVB DNA damage response pathway involving interferon and TNF signaling to induce keratinocyte cell death.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1592636</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1592636</link>
        <title><![CDATA[Corrigendum: Identification of miR-342-5p/MDM4/p53 network in acute myeloid leukemia]]></title>
        <pubdate>2025-04-25T00:00:00Z</pubdate>
        <category>Correction</category>
        <author>Sema Misir</author><author>Serap Ozer Yaman</author><author>Ceylan Hepokur</author><author>Osman Akidan</author><author>Yuksel Aliyazicioglu</author><author>Francisco J. Enguita</author><author>Mazhar Salim Al Zoubi</author>
        <description></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1583221</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1583221</link>
        <title><![CDATA[The good, the bad, and the modified: CYLD’s post-translational tale]]></title>
        <pubdate>2025-04-09T00:00:00Z</pubdate>
        <category>Mini Review</category>
        <author>Yanis M. Macé</author><author>Nicolas Bidère</author><author>Tiphaine Douanne</author>
        <description><![CDATA[The deubiquitinating enzyme CYLD hydrolyzes Lys63-and Met1-linked ubiquitin chains, playing a crucial role in regulating various cellular processes such as immune cell development, innate and adaptive immunity, spermatogenesis, ciliogenesis, and cell survival. CYLD also functions as a tumor suppressor and is mutated in familial cylindromatosis. This pleiotropic function implies tight regulatory mechanisms. In this review, we summarize the current knowledge on CYLD’s molecular characteristics, subcellular location, and binding partners, with a focus on its involvement in life-and-death decisions. In addition, we discuss how post-translational modifications, including phosphorylation, ubiquitination, and proteolysis, shape CYLD’s function, unveiling the potential for therapeutic intervention. Finally, we highlight the remaining challenges that need to be overcome to deepen our understanding of this crucial enzyme.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1585989</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1585989</link>
        <title><![CDATA[Glycans on death receptors as sweet markers and signaling checkpoints]]></title>
        <pubdate>2025-04-08T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Kamil Seyrek</author><author>Johannes Espe</author><author>Corinna König</author><author>Fabian Wohlfromm</author><author>Inna N. Lavrik</author>
        <description><![CDATA[Apoptosis is a form of programmed cell death that eliminates excessive and damaged cells. It can be conducted by two ways: the extrinsic and the intrinsic (mitochondrial) pathways. The extrinsic death pathway is triggered by activation of the death receptors (DRs), while the intrinsic pathway is initiated by changes at the mitochondria. The induction of life and death signals via DRs requires an intricate regulation of signal transduction. In this regard, an optimal conformation of the extracellular domain of DR is required for the Death Ligand (DL) binding and initiation of DR signaling. Glycosylation, the enzymatic attachment of carbohydrates to proteins, can influence DR conformation and thereby receptor-ligand interaction. Due to the tremendous structural diversity of glycans attached to DRs, little is known about the role of specific glycosylation subtypes influencing functions of DRs. Deciphering the role of specific glycan signatures, so-called “glyco-code”, on DRs is important to understand how glycans are involved in signal transduction. Although apoptosis has been shown to be associated with altered glycosylation patterns of glycoproteins, our understanding how glycosylation modulates apoptosis is still limited. This review focuses on summarizing our current knowledge on the modulation of cell signaling via glycosylation of DRs.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2025.1470093</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2025.1470093</link>
        <title><![CDATA[Exploring sugar-induced cell death in yeast: implications for diabetes and cancer research]]></title>
        <pubdate>2025-03-19T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Raveena Parbhudayal</author><author>Hai-Ping Cheng</author>
        <description><![CDATA[When yeast cells are transferred to water only, they remain viable for several days. However, when transferred to water with glucose, there is a rapid loss of viability. This phenomenon is termed Sugar-Induced Cell Death (SICD). In addition to glucose, SICD can be induced by an array of different sugars and is thought to be triggered by increased levels of intracellular reactive oxygen species (ROS) generated upon transfer to sugar-only solutions. Although not termed SICD, a similar response is observed in mammalian cells, whereby high glucose induces cell death, especially in cases of hyperglycemia and diabetes. In contrast, cancer cells thrive under conditions of high glucose. In this review, we summarize the current understanding of SICD in yeast and highlight studies showing the presence of a similar phenomenon in mammalian cells, High Glucose-Induced Cell Death (HGICD). We end with a discussion on mechanisms by which cancer cells evade HGICD. Unlike other types of cell death in yeast, SICD has not yet been thoroughly reviewed. Therefore, this review represents the first comprehensive review of SICD in yeast with a comparison to HGICD in other eukaryotes.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2024.1507960</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2024.1507960</link>
        <title><![CDATA[ATF4-mediated expression of NOXA is critical for necroptosis driven by glucose deprivation]]></title>
        <pubdate>2025-01-20T00:00:00Z</pubdate>
        <category>Brief Research Report</category>
        <author>Sasiprapa Sonkaew</author><author>Ruwaida Rajna</author><author>Yeon-Ji Park</author><author>Jiong Yan</author><author>Zhaoshan Liu</author><author>Siriporn Jitkaew</author><author>Zheng-Gang Liu</author><author>Swati Choksi</author>
        <description><![CDATA[Glucose deprivation (GD), a common metabolic stress condition, has been recognized as a potent inducer of necroptotic cell death. Our previous findings suggested that the mitochondrial protein, Noxa, may be involved in mediating the release of mitochondrial DNA during GD-induced ZBP1-dependent necroptotic pathway. However, the functional significance of Noxa in necroptosis under GD treatment remains unclear. Here, we investigated the role of Noxa in GD-induced necroptosis and the underlying molecular mechanisms governing its expression. We revealed that Noxa is required for the induction of necroptosis under GD. We also demonstrated that the upregulation of Noxa induced by GD is mediated by ATF4, a key transcription factor. These results provide insights into the regulatory mechanisms underlying Noxa dynamics during GD treatment and highlights its potential as a therapeutic target in cancer therapy and necroptosis-related diseases.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2024.1503799</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2024.1503799</link>
        <title><![CDATA[Regulation of pyroptosis by NF-κB signaling]]></title>
        <pubdate>2025-01-07T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Ling Yang</author><author>Yan Zhang</author><author>Zhuodong Chai</author><author>Yuqi Zhou</author><author>Zhenyu Li</author><author>Yinan Wei</author>
        <description><![CDATA[Pyroptosis is a form of proinflammatory cell death characterized by inflammasome activation, pore formation, and the release of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and IL-18 upon cell rupture. Nuclear factor-κB (NF-κB), a prototypical pro-inflammatory transcription factor, plays a critical role in immune system regulation. Recent research highlights the multifaceted roles of NF-κB signaling in pyroptosis. Various immunologically relevant ligands and their receptors can activate the NF-κB pathway to promote pyroptosis, with Toll-like receptors (TLRs), IL-1 receptors (IL-1Rs), and TNF receptors (TNFRs) being the most prominent. NF-κB regulates the transcription of key components of inflammasomes involved in pyroptosis, particularly the NLRP3 inflammasome. Recent studies also indicate that NF-κB modulates the activation of NLRC4 and AIM2 inflammasomes through distinct pathways in diverse inflammatory conditions, such as acute lung injury and neuroinflammation. Additionally, the NF-κB pathway mediates the production of inflammatory cytokines, including IL-1β, IL-33, and TNF-α, which further regulate pyroptosis. This review examines recent advances in understanding the role of the NF-κB signaling pathway in regulating pyroptosis during infection and inflammation.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2024.1467272</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2024.1467272</link>
        <title><![CDATA[Mitochondrial (dys) function: a double edge sword in cell stress response]]></title>
        <pubdate>2024-12-18T00:00:00Z</pubdate>
        <category>Perspective</category>
        <author>Nicoletta Guaragnella</author><author>Maria Antonietta Di Noia</author><author>Angela Primavera</author>
        <description><![CDATA[Mitochondria are multifaceted organelles acting as energy, metabolic and signaling hubs in the cells. They play a central role in biological processes aimed at maintaining cell homeostasis and regulating cell fate upon changing environments. Alterations in mitochondrial functions can affect cell stress response through different mechanisms, leading to adaptation or death. In this perspective, we focus on mitochondrial communication and its relevance for cytoprotective strategies aimed at controlling synthesis, degradation and recycling processes. The advantage of using yeast as a model organism for improving our understanding of the molecular mechanisms behind cell stress responses to mitochondrial dysfunction is described. New challenges for studying the interplay between mitochondrial retrograde signaling and autophagy/mitophagy pathways are highlighted.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2024.1478258</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2024.1478258</link>
        <title><![CDATA[Exploring advanced Drosophila cell death techniques and cancer-related studies]]></title>
        <pubdate>2024-11-26T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Daniel Tendero-Lopez</author><author>Maria Dominguez</author><author>Mary Luz Uribe</author>
        <description><![CDATA[Cell death is an essential physiological process for the survival of multicellular organisms. Our understanding of programmed cell death in development, immune function maintenance, and adult tissue repair has significantly advanced over the past decade. However, there are still gaps in our knowledge about the induction, regulation, and checkpoints of this process due to the diverse forms of cellular suicide and the rapid nature of the process. Molecular advancements such as specific cell death sensors, RNA-seq, single-cell RNA-seq, and proteomics have allowed for identifying new factors and a better understanding of the molecular networks and pathways that regulate these processes. Programmed cell death also plays a role in cancer, both limiting and facilitating aspects of the malignant process, making its analysis and inhibition challenging. This review discusses the field’s advancements using the model organism Drosophila melanogaster, the types of cell death in development and adult tissues, the techniques for studying it, and its role in cancer.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2024.1471050</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2024.1471050</link>
        <title><![CDATA[The histone demethylase Kdm5 controls Hid-induced cell death in Drosophila]]></title>
        <pubdate>2024-11-20T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Hans-Martin Herz</author><author>Andreas Bergmann</author>
        <description><![CDATA[We conducted an EMS mutagenesis screen on chromosome arm 2L to identify recessive suppressors of GMR-hid-induced apoptosis in the Drosophila eye. Through this screen, we recovered three alleles of the lysine demethylase gene Kdm5. Kdm5, a member of the JmjC-domain-containing protein family, possesses histone demethylase activity towards H3K4me3. Our data suggest that Kdm5 specifically regulates Hid-induced cell death during development, as we did not observe control of Reaper- or Grim-induced cell death by Kdm5. Interestingly, GMR-hid-induced apoptosis is suppressed independently of Kdm5’s demethylase activity. Our findings indicate that Rbf and dMyc are necessary for Kdm5 mosaics to suppress GMR-hid-induced cell death. Moreover, Kdm5 mosaics failed to suppress apoptosis induced by a mutant form of Hid that is resistant to inhibition by Erk-type MAPK activity. Additionally, Kdm5 dominantly enhances the wing phenotype of an activated MAPK mutant. These results collectively suggest that Kdm5 controls Hid-induced apoptosis by regulating the Rbf, dMyc, and MAPK pathways.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2024.1503241</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2024.1503241</link>
        <title><![CDATA[Identification of miR-342-5p/MDM4/p53 network in acute myeloid leukemia]]></title>
        <pubdate>2024-11-14T00:00:00Z</pubdate>
        <category>Original Research</category>
        <author>Sema Misir</author><author>Serap Ozer Yaman</author><author>Ceylan Hepokur</author><author>Osman Akidan</author><author>Yuksel Aliyazicioglu</author><author>Francisco J. Enguita</author><author>Mazhar Salim Al Zoubi</author>
        <description><![CDATA[Acute myeloid leukemia (AML) is one of the most prevalent hematological malignancies. miRNAs play roles in cancer initiation and progression in various cancer types by post-transcriptional regulation of gene expression. The aim of this study is to investigate the mechanisms in the development and progression of acute myeloid leukemia and to identify potential target genes and miRNAs by bioinformatic analysis. miRNA expression profiles were obtained from the GSE51908 dataset on the Gene Expression Omnibus (GEO). GEO2R was used to identify differentially expressed miRNAs. The diagnostic and overall survival effects of the identified miRNA were determined using ROC analysis and Kaplan-Meier curve, respectively. Putative miRNA targets were determined based on miRWalk and miRDB tools. The expression change and overall survival analysis of the identified target gene were analyzed by Gene Expression Profiling Interactive Analysis (GEPIA). Protein-protein interaction (PPI) networks of the target gene were determined using STRING and GeneMANIA. Functional enrichment analysis was performed using the DAVID program. 24 DE-miRNAs were identified, including 16 upregulated and 8 downregulated genes. miR-342-5p expression had significantly shorter survival than those in higher expression control group (p = 0.0001), and its AUC value to discriminate AML from control groups was 0.795. High expression of MDM4 predicts an unfavorable prognosis in AML patients. The MDM4 gene was determined to be associated with decreased survival rates. According to KEGG results, microRNAs, p53 signaling pathway, and cell cycle are associated with AML development. The current study based on the GEO database, miR-342-5p/MDM4/p53 axis AML may provide new therapeutic targets.]]></description>
      </item><item>
        <guid isPermaLink="true">https://www.frontiersin.org/articles/10.3389/fceld.2024.1472108</guid>
        <link>https://www.frontiersin.org/articles/10.3389/fceld.2024.1472108</link>
        <title><![CDATA[Exploring caspase-dependent non-lethal cellular processes using Drosophila]]></title>
        <pubdate>2024-10-21T00:00:00Z</pubdate>
        <category>Review</category>
        <author>Natsuki Shinoda</author><author>Masayuki Miura</author>
        <description><![CDATA[Caspases are cysteine aspartic acid proteases conserved in animals that not only execute apoptosis, but also regulate diverse cellular processes independent of apoptosis, which are termed caspase-dependent non-lethal cellular processes (CDPs). Owing to its strong genetics to detect and manipulate caspase activity in cells of interest in vivo, Drosophila melanogaster serves as an excellent model organism for analyzing CDPs. This is further supported by the fact that apoptotic signaling, as well as CDPs and their mechanisms, are, in part, conserved in other animals. Here, we present a review to guide researchers studying CDPs using Drosophila. In this review, we provide an overview of the current understanding of apoptotic signaling, which regulates caspase activation in Drosophila as well as available genetic tools and their characteristics for detecting and manipulating caspase activity so that researchers can choose appropriate tools for their own experimental settings. We also introduce the CDPs identified in Drosophila, including a brief description of their discovery and characterization as non-lethal processes. We further describe the underlying molecular mechanisms of several well-characterized CDPs, including the regulatory mechanisms that enable non-lethal caspase activation. Finally, we introduce the use of proximity labeling techniques, especially TurboID, for studying CDPs, which facilitates the analysis of underlying molecular mechanisms. Because caspases regulate various non-lethal cellular functions, their activation is no longer considered a point of no return in cell death. Understanding CDPs will advance our understanding of the states of living and dying cells, along with the intermediate states.]]></description>
      </item>
      </channel>
    </rss>